NOVARTIS N (NOT.SG)
NOVARTIS N (NOT.SG) operates in Diversified Metals & Mining.
NOVARTIS N (NOT.SG) (NOT) - Total Assets
Latest total assets as of September 2024: €103.52 Billion EUR
Based on the latest financial reports, NOVARTIS N (NOT.SG) (NOT) holds total assets worth €103.52 Billion EUR as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
NOVARTIS N (NOT.SG) - Total Assets Trend (2014–2023)
This chart illustrates how NOVARTIS N (NOT.SG)’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
NOVARTIS N (NOT.SG) - Asset Composition Analysis
Current Asset Composition (December 2023)
NOVARTIS N (NOT.SG)'s total assets of €103.52 Billion consist of 30.5% current assets and 69.5% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 13.4% |
| Accounts Receivable | €7.11 Billion | 7.1% |
| Inventory | €5.91 Billion | 5.9% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €26.88 Billion | 26.9% |
| Goodwill | €23.34 Billion | 23.4% |
Asset Composition Trend (2014–2023)
This chart illustrates how NOVARTIS N (NOT.SG)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NOVARTIS N (NOT.SG)'s current assets represent 30.5% of total assets in 2023, an increase from 30.0% in 2014.
- Cash Position: Cash and equivalents constituted 13.4% of total assets in 2023, up from 10.4% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 49.0% of total assets, an increase from 40.0% in 2014.
- Asset Diversification: The largest asset category is intangible assets at 26.9% of total assets.
NOVARTIS N (NOT.SG) Competitors by Total Assets
Key competitors of NOVARTIS N (NOT.SG) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
XIWANG SPECIAL STEE (2XI.SG)
STU:2XI
|
Germany | €15.07 Billion |
|
LINDT & SPRUENGLI N - Dusseldorf Stock Exchang
DU:LSPN
|
Germany | €7.86 Billion |
|
PRICELINE.COM
BE:PCE1
|
Germany | €27.98 Billion |
|
PRICELINE GROUP (PCE1.SG)
STU:PCE1
|
Germany | €27.98 Billion |
|
MURPHY USA
BE:1MU
|
Germany | €4.40 Billion |
|
RESMED (RME.SG)
STU:RME
|
Germany | €7.22 Billion |
|
DIOS EXPLORATIONS
BE:BFM
|
Germany | €7.25 Million |
|
CHINA YUCHAI INTL (CYD.SG)
STU:CYD
|
Germany | €25.76 Billion |
NOVARTIS N (NOT.SG) - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - NOVARTIS N (NOT.SG) generates 0.47x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, NOVARTIS N (NOT.SG) generates $ 14.86 in net profit.
NOVARTIS N (NOT.SG) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.11 | 0.94 | 1.04 |
| Quick Ratio | 0.90 | 0.83 | 0.83 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €3.13 Billion | € -2.73 Billion | € 1.24 Billion |
NOVARTIS N (NOT.SG) - Advanced Valuation Insights
This section examines the relationship between NOVARTIS N (NOT.SG)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -14.9% |
| Total Assets | €99.94 Billion |
| Market Capitalization | $1.33 Million USD |
Valuation Analysis
Below Book Valuation: The market values NOVARTIS N (NOT.SG)'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: NOVARTIS N (NOT.SG)'s assets decreased by 14.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for NOVARTIS N (NOT.SG) (2014–2023)
The table below shows the annual total assets of NOVARTIS N (NOT.SG) from 2014 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | €99.94 Billion | -14.91% |
| 2022-12-31 | €117.45 Billion | -10.88% |
| 2021-12-31 | €131.79 Billion | +3.14% |
| 2020-12-31 | €127.78 Billion | +7.95% |
| 2019-12-31 | €118.37 Billion | -18.68% |
| 2018-12-31 | €145.56 Billion | +9.38% |
| 2017-12-31 | €133.08 Billion | +2.27% |
| 2016-12-31 | €130.12 Billion | -1.09% |
| 2015-12-31 | €131.56 Billion | +4.92% |
| 2014-12-31 | €125.39 Billion | -- |